Aurora Diagnostics Acquires Cleveland Skin Pathology Laboratory
News May 16, 2017
Aurora Diagnostics has announced the acquisition of Cleveland Skin Pathology Laboratory Inc.
Founded in 1972, Cleveland Skin Pathology Laboratory is a physician-owned medical practice providing dermatopathology services to dermatologists, surgeons, and primary care providers, with concentration in the Midwest but with coast-to-coast reach. The practice has six board-certified dermatopathologists, who are also board-certified in pathology or dermatology. All of the doctors are committed academicians actively engaged within their specialty areas.
“We are very pleased to welcome the highly respected Cleveland Skin Pathology Laboratory team to our growing family of pathology practices,” said Daniel D. Crowley, President, Chairman and CEO of Aurora Diagnostics. “Their history of working in a collaborative environment and being available to discuss cases with referring clinicians is an approach that we appreciate and encourage at Aurora Diagnostics.”
“We are all excited to be part of the Aurora Diagnostics team” said Jonathan Bass, MD, President of Cleveland Skin Pathology. “Aurora is an excellent cultural fit, with its commitment to community-based pathology practices. In addition, the company brings valuable resources dedicated to information technology, payor relations, human resources, and purchasing. We look forward to working with a team of committed colleagues and providing many more decades of diagnostic excellence to the physicians and patients we serve.”
Terms of the transaction were not disclosed.
Training Evolution in Pathology Needed to Deliver Precision MedicineNews
The future delivery of precision medicine is at risk unless pathology training programmes evolve to embrace genomics, warn UK researchers.READ MORE
New Techniques Give Blood Biopsies Greater PromiseNews
Researchers at the Broad Institute of MIT and Harvard, Koch Institute at MIT, Dana-Farber Cancer Institute, and Massachusetts General Hospital Cancer Center have developed an accurate, scalable approach for monitoring cancer DNA from blood samples.READ MORE
New Blood Test Developed to Diagnose Ovarian CancerNews
Investigators from Brigham and Women’s Hospital and Dana-Farber Cancer Institute are leveraging the power of artificial intelligence to develop a new technique to detect ovarian cancer early and accurately.READ MORE